Mallika Singh

Mallika Singh

Company: Revolution Medicines

Job title: VP, Translational Research


Targeting RAS Mutant GI Cancers – Treatment Strategies and Resistance Mechanisms 9:30 am

Unmet medical need in RAS mutant GI cancers RAS(ON) Targeted Therapies for RAS mutant GI cancers: mutantselective and RASMulti inhibitors Application of biomarker-driven combination strategiesRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.